close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

92.04 +1.01 (+1.11%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
GeneDx to Participate in Upcoming Investor Conferences in June
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations
Keynote session to highlight value of GeneDx genomic data and clinical insights to accelerate genetic neurodevelopmental disorder pipeline for Mahzi Therapeutics 
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
Recap: GeneDx Hldgs Q1 Earnings ↗
 
Via Benzinga
News headline image
Earnings Preview: GeneDx Hldgs ↗
 
Via Benzinga
News headline image
Why Shares of GeneDx Dropped Wednesday ↗
The potential of a reverse split concerned investors. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 199 companies reached new 52-week lows. 
Via Benzinga
News headline image
GeneDx Reports First Quarter 2023 Financial Results and Business Highlights
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option
New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis 
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx Holdings's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 9, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. 
Via Benzinga
News headline image
GeneDx Announces Clarification Regarding CUSIP Number for Public Warrant Holders
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
Why GeneDx Holdings Stock Lagged the Market Today ↗
A financial-engineering move about to be made by the company is an indication of some deep and challenging problems. 
Via The Motley Fool
News headline image
GeneDx Announces Reverse Stock Split
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time for another dive into the biggest pre-market stock movers with all the hot topics traders need to know about on Friday! 
Via InvestorPlace
News headline image
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share. 
Via Benzinga
News headline image
First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
The 7 Worst Stocks to Buy Now ↗
With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now. 
Via InvestorPlace
News headline image
GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray
New research released at ACMG Annual Clinical Genetics Meeting reiterates the superiority of exome sequencing’s role in shortening the diagnostic odyssey 
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx to Participate in the Cowen 43rd Annual Healthcare Conference
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
Research illustrates company’s progress in working to end the diagnostic odyssey and includes data with implications for how care is delivered to patients beginning at birth 
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous... 
Via Benzinga
News headline image
GeneDx to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 14th, 2023
From GeneDx Holdings Corp.
Via GlobeNewswire
News headline image
Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket ↗
Gainers Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today